Wearable Atrial Fibrillation Detection Devices Market Size & Share 2025 - 2034

Wearable Atrial Fibrillation Detection Devices Market Size

The global wearable atrial fibrillation detection devices market was valued at USD 596.2 million in 2024. The market is anticipated to grow from USD 703.1 million in 2025 to USD 3 billion in 2034, growing at a CAGR of 17.4% from 2025 to 2034. High market growth is primarily driven by the rising incidence of atrial fibrillation, increased awareness about the condition, and growing demand for remote monitoring solutions.

The increasing prevalence of atrial fibrillation is closely linked to the global rise in life expectancy, which contributes to aging populations worldwide. For example, according to the European Society of Cardiology, by 2025, one in three individuals globally is expected to develop a potentially life-threatening heart rhythm disorder during their lifetime. Additionally, the Journal of Clinical Medicine Research reports that 8.8% of the U.S. population aged 80 years or older is affected by atrial fibrillation. Wearable devices such as smartwatches and fitness trackers, equipped with advanced artificial intelligence algorithms, offer a cost-effective and user-friendly solution for early atrial fibrillation detection.
 

Wearable atrial fibrillation detection devices are innovative, easy-to-use tools designed to monitor heart health and detect irregular heart rhythms like atrial fibrillation. These devices, available as smartwatches, patches, or handheld monitors, utilize advanced sensors to track the heart’s electrical signals or blood flow patterns.
 

Wearable Atrial Fibrillation Detection Devices Market Trends

The market for wearable atrial fibrillation detection devices is experiencing rapid growth, driven by continuous technological advancements.
 

• Smaller and more powerful sensors have enabled the integration of advanced monitoring technology into compact, wearable devices. This miniaturization allows users to wear these devices throughout the day without hindering their daily activities.
   
• Enhanced electrocardiogram (ECG) monitoring capabilities have significantly improved the efficiency of wearable atrial fibrillation devices. These devices now provide real-time cardiac rhythm evaluations, increasing the accuracy of atrial fibrillation detection.
   
• Additionally, the incorporation of machine learning and artificial intelligence technologies into wearable AF devices represents a major breakthrough. By utilizing advanced algorithms to analyze heart rhythm data, these wearables can effectively identify patterns that may indicate atrial fibrillation. These innovations are expected to drive market growth further.
   

Wearable Atrial Fibrillation Detection Devices Market Analysis

In 2021, the global wearable atrial fibrillation detection devices market was valued at USD 415.1 million. The following year, it saw a slight increase to USD 467.4 million, and by 2023, the market further climbed to USD 530.1 million. Based on product type, the global market is segmented into smartwatches, patch monitors, and portable ECG monitors. The smartwatches segment accounted for the leading market share and was valued at USD 370.5 million in 2024.
 

• Compared to traditional heart rate monitors or fitness bands, smartwatches offer a wide range of features, including fitness tracking, notification management, and communication capabilities, all integrated into a single device. This combination of functionalities appeals to consumers seeking convenience and a user-friendly interface.
   
• Moreover, smartwatches equipped with advanced sensors and algorithms can perform continuous ECG monitoring, providing real-time insights into heart rhythms.
   
• Leading companies in the smartwatch market have incorporated cutting-edge technology to help users detect irregularities that may indicate atrial fibrillation. For example, industry leaders like Apple and Samsung have pioneered the integration of ECG functionality into their devices, enhancing consumer trust and encouraging adoption.
   

Based on technology, the global market is segmented into photoplethysmography (PPG) based and electrocardiogram (ECG) based. The photoplethysmography (PPG) based segment accounted for the leading share in the market in 2024 and is expected to reach around USD 2 billion in 2034.
 

• PPG allows users to monitor heart rates and detect atrial fibrillation without the need for invasive procedures. This ease of use has made it widely adopted in consumer-grade devices, such as smartwatches and fitness trackers.
   
• Additionally, devices equipped with PPG sensors offer continuous heart rate monitoring, leading to timely alerts for atrial fibrillation detection and enabling users to take proactive measures regarding their health.
   
• PPG sensors are less expensive to manufacture than traditional ECG sensors, leading to more affordable devices for consumers. This accessibility has contributed to the growing popularity of PPG-based devices in the wearable health telemetry market.

Learn more about the key segments shaping this market

Download Free PDF

 

Based on distribution channel, the global wearable atrial fibrillation detection devices market is classified into e-commerce and brick and mortar. In 2024, the e-commerce segment held the 69.1% share and is expected to showcase significant growth over the analysis period.
 

• Online marketplaces typically provide a wider range of devices compared to physical retail stores, offering various brands, models, and price ranges.
   
• Additionally, e-commerce platforms allow consumers to shop at their convenience, eliminating time restrictions associated with traditional shopping.
   
• These platforms also enable consumers to compare products and prices effortlessly, helping them make well-informed purchasing decisions.
   

The North America wearable atrial fibrillation detection devices market accounted for the leading share and was valued at USD 281.4 million in 2024. Continuous technological advancements, coupled with a rise in awareness levels and increasing prevalence of atrial fibrillation, are expected to drive regional growth.
 

The U.S. wearable atrial fibrillation detection devices market was valued at USD 189.9 million and USD 211.9 million in 2021 and 2022, respectively. The market size reached USD 265.3 million in 2024, growing from USD 238.1 million in 2023.
 

• The U.S. continues to dominate the wearable atrial fibrillation detection devices market, supported by advanced technological developments, high healthcare spending, and a growing focus on preventive healthcare.
   
• With an aging population increasingly at risk of atrial fibrillation, many individuals in the U.S. are adopting wearable devices to monitor their heart health effectively. As per Population Reference Bureau (PRB), the population in the U.S. aged 65 and older is expected to increase from 58 million in 2022 to 82 million by 2050, reflecting a 47% growth.
   
• A well-established network of healthcare providers and technology companies dedicated to innovative health solutions further drives the growth of this market.
   

The Europe wearable atrial fibrillation detection devices market accounted for a significant revenue share and was valued at around USD 132.3 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Countries such as Germany, France, and the UK lead in adopting advanced health technology solutions. The growing awareness among European consumers regarding health monitoring and data-driven decision-making has significantly increased the demand for wearable devices.
   
• Additionally, regulatory authorities in Europe have implemented frameworks that promote innovation while ensuring product safety and effectiveness. This has strengthened consumer confidence and accelerated the adoption of these wearable devices.
   

The Germany wearable atrial fibrillation detection devices market is expected to witness considerable growth over the analysis period.
 

• Germany, as one of the largest healthcare markets in Europe, places significant importance on healthcare innovation and the adoption of advanced technologies.
   
• The country’s robust healthcare infrastructure and the integration of digital health solutions into routine medical practices have driven the widespread acceptance of wearable health devices.
   
• Moreover, German consumers are becoming increasingly health-conscious, which has fueled the demand for wearables that enable continuous monitoring and early detection of conditions such as atrial fibrillation. As per Statista, in 2023, nearly 20 million individuals in Germany considered themselves health-conscious.
   

The Asia Pacific wearable atrial fibrillation detection devices market is anticipated to grow at the highest CAGR of 19.8% during the analysis timeframe.
 

• The Asia Pacific region is experiencing significant growth in the wearable atrial fibrillation detection devices market, driven by rising disposable incomes and an increasing emphasis on health and fitness.
   
• The growing prevalence of cardiovascular diseases, attributed to lifestyle changes, urbanization, and an aging population, is further boosting the adoption of these wearable devices.
   
• Moreover, technological advancements and the expanding ecosystem of fitness and health-related applications are enhancing the appeal of these wearables to consumers.
   

China wearable atrial fibrillation detection devices market is predicted to grow significantly over the forecast period.
 

• The Chinese government’s emphasis on healthcare reforms and the incorporation of technology into personal healthcare management have significantly increased the adoption of digital health devices.
   
• Moreover, the expansion of e-commerce platforms in China has enhanced access to wearable devices, enabling consumers to make more informed health decisions.
   

Brazil is experiencing significant growth in the Latin America wearable atrial fibrillation detection devices market and is anticipated to record robust growth throughout the forecast period.
 

• With a significant aging population and increasing prevalence of hypertension and diabetes, the need for early detection and continuous monitoring solutions is growing.
   
• Brazil's adoption of digital health technologies, such as smartwatches and wireless ECG devices, is being driven by government initiatives aimed at enhancing public health outcomes.
   
• Furthermore, the country's expanding telemedicine ecosystem is improving access to atrial fibrillation monitoring, particularly in remote and underserved areas.
   

Saudi Arabia's is poised to witness substantial growth in the Middle East and Africa wearable atrial fibrillation detection devices market during the forecast period.
 

• The country is making significant investments in digital health and smart medical technologies to address the growing burden of non-communicable diseases, including cardiovascular conditions.
   
• Given the high prevalence of lifestyle-related risk factors such as obesity and diabetes, the demand for proactive heart health monitoring has become increasingly critical.
   

Wearable Atrial Fibrillation Detection Devices Market Share

Companies operating in the wearable atrial fibrillation detection devices industry are actively investing in expanding their product lines while enhancing technical performance and user experience. Leading players, including Apple, Google, and Philips, are focusing on developing advanced wearable atrial fibrillation detection devices with improved, smaller sensors, real-time arrhythmia detection, and AI integration. These advancements aim to enhance detection procedures and ultimately improve patient outcomes. The top 5 players in the market collectively hold a share of 35%, with a focus on harnessing innovative technologies to meet the growing demand for effective ECG detection.
 

Wearable Atrial Fibrillation Detection Devices Market Companies

Few of the prominent players operating in the wearable atrial fibrillation detection devices industry include:

• ALIVECOR
• Apple
• ATsens
• CardiacSense
• Circular
• Garmin
• Google
• Huawei
• iRHYTHM
• PHILIPS
• QARDIO
• Samsung
• Withings

• AliveCor is a pioneer in mobile ECG technology, best known for its KardiaMobile device, a compact, FDA-cleared, single-lead ECG monitor that enables users to detect atrial fibrillation within 30 seconds. AliveCor’s devices are supported by AI algorithms that enhance diagnostic precision and integrate seamlessly with smartphones, allowing users to track heart health remotely.
   
• Philips is involved in the development of advanced wearable atrial fibrillation detection devices that emphasize clinical-grade biosensing and seamless healthcare integration. Leveraging its expertise in medical technology, Philips designs wearables equipped with multi-sensor capabilities, including ECG and photoplethysmography (PPG), to ensure accurate and continuous heart rhythm monitoring.
   
• Google leverages its expertise in AI to enhance the accuracy in detecting atrial fibrillation. The algorithm used by Google can analyze heart rhythm patterns in real time to predict the occurrence of potential atrial fibrillation episodes, even before they occur.
   

Wearable Atrial Fibrillation Detection Devices Industry News

• In January 2025, Withings announced the launch of Cardio Check-Up, an innovative in-app service that connects users with expert cardiologists for professional evaluation of ECG measurements. Cardio Check-Up is compatible with all current and future Withings devices featuring ECG capabilities. These include the hybrid smartwatches ScanWatch, ScanWatch 2, ScanWatch Nova, and the newly launched ScanWatch Nova Brilliant, as well as the Body Scan connected scale, the Move ECG and BPM Core connected monitors, and the advanced 4-in-1 MultiScan checkup device, BeamO.
   
• In January 2025, Circular announced the launch of next-generation Ring 2, that supports feature such as ECG functionality and atrial fibrillation detection capabilities. Through Ring 2, Circular aims to leverage an increasing focus on preventive health by providing a scalable solution that can seamlessly integrate with broader healthcare systems for efficient patient monitoring.
   
• In June 2024, AliveCor announced the launch and FDA clearance of the Kardia 12L ECG System. This device is a handheld, AI-powered 12-lead ECG system featuring a unique single-cable design with five electrodes that can acquire eight high-quality diagnostic leads. This development highlights the company's strategy and focuses on innovation to remain in a leading position in comparison to its peers.
   
• In December 2023, Withings announced the launch of ScanWatch Nova, a device equipped with advanced health-tracking features. This smartwatch is designed to provide continuous and autonomous measurements, boasting a 30-day battery life. ScanWatch Nova also includes the capability to perform on-demand medical-grade electrocardiograms, enabling the detection of potential heart anomalies, such as atrial fibrillation, at any time.
   

The wearable atrial fibrillation detection devices market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Smartwatches
• Patch monitors
• Portable ECG monitors

Market, By Technology

• Photoplethysmography (PPG) based
• Electrocardiogram (ECG) based

Market, By Distribution Channel

• E-commerce
• Brick and mortar

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE